RELAPSE MULTIPLE MYELOMA
Clinical trials for RELAPSE MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSE MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSE MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Hard-to-Treat myeloma
Disease control OngoingThis study tests a combination of four drugs (daratumumab, clarithromycin, pomalidomide, and dexamethasone) in people with multiple myeloma whose cancer returned or stopped responding after previous treatment with daratumumab. The goal is to see if this combo can shrink tumors mo…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Italian study tracks Real-World outcomes for Triple-Refractory myeloma
Knowledge-focused OngoingThis study looks at how doctors in Italy currently treat a tough type of multiple myeloma that doesn't respond to the three main drug classes. Researchers will collect information from medical records of about 250 patients to see how well treatments work in real life and what the…
Matched conditions: RELAPSE MULTIPLE MYELOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC